Literature DB >> 7805693

Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis.

F Bolao1, D Podzamczer, M Ventin, F Gudiol.   

Abstract

An AIDS patient with sporotrichosis who improved with itraconazole therapy after consecutive failure of ketoconazole, saturated solution of potassium iodide, fluconazole and amphotericin B is presented. In addition, long-term therapy with high doses of itraconazole was well tolerated and effective in avoiding relapse. Itraconazole may be suitable for use in HIV-infected patients with sporotrichosis, who probably require chronic suppressive therapy to prevent relapse of symptomatic disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805693     DOI: 10.1007/bf01971316

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Disseminated sporotrichosis in a patient with HIV infection after treatment for acquired factor VIII inhibitor.

Authors:  M R Bibler; H J Luber; H I Glueck; S A Estes
Journal:  JAMA       Date:  1986-12-12       Impact factor: 56.272

Review 2.  Disseminated sporotrichosis in patients with AIDS: case report and review of the literature.

Authors:  H M Heller; J Fuhrer
Journal:  AIDS       Date:  1991-10       Impact factor: 4.177

3.  Itraconazole therapy in lymphangitic and cutaneous sporotrichosis.

Authors:  A Restrepo; J Robledo; I Gómez; A M Tabares; R Gutiérrez
Journal:  Arch Dermatol       Date:  1986-04

4.  Itraconazole therapy in aspergillosis: study in 49 patients.

Authors:  B Dupont
Journal:  J Am Acad Dermatol       Date:  1990-09       Impact factor: 11.527

5.  European experience with itraconazole in systemic mycoses.

Authors:  M A Viviani; A M Tortorano; A Pagano; G M Vigevani; G Gubertini; S Cristina; M L Assaisso; F Suter; C Farina; B Minetti
Journal:  J Am Acad Dermatol       Date:  1990-09       Impact factor: 11.527

6.  Sporotrichosis in the acquired immunodeficiency syndrome.

Authors:  J C Shaw; W Levinson; A Montanaro
Journal:  J Am Acad Dermatol       Date:  1989-11       Impact factor: 11.527

7.  Treatment of invasive aspergillosis with itraconazole.

Authors:  D W Denning; R M Tucker; L H Hanson; D A Stevens
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

8.  Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group.

Authors:  P K Sharkey-Mathis; C A Kauffman; J R Graybill; D A Stevens; J S Hostetler; G Cloud; W E Dismukes
Journal:  Am J Med       Date:  1993-09       Impact factor: 4.965

9.  Disseminated Sporothrix schenckii infection with arthritis in a patient with acquired immunodeficiency syndrome.

Authors:  E Lipstein-Kresch; H D Isenberg; C Singer; O Cooke; R A Greenwald
Journal:  J Rheumatol       Date:  1985-08       Impact factor: 4.666

10.  Sporothrix schenckii endophthalmitis in a patient with human immunodeficiency virus infection.

Authors:  A Kurosawa; S C Pollock; M P Collins; C R Kraff; M O Tso
Journal:  Arch Ophthalmol       Date:  1988-03
View more
  2 in total

Review 1.  The impact of sporotrichosis in HIV-infected patients: a systematic review.

Authors:  José A S Moreira; Dayvison F S Freitas; Cristiane C Lamas
Journal:  Infection       Date:  2015-02-21       Impact factor: 3.553

Review 2.  Cutaneous Disseminated and Extracutaneous Sporotrichosis: Current Status of a Complex Disease.

Authors:  Alexandro Bonifaz; Andrés Tirado-Sánchez
Journal:  J Fungi (Basel)       Date:  2017-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.